Search Results - "Hiligsmann M"

The impact of fracture liaison services on subsequent fractures and mortality: a systematic literature review and meta-analysis.

Authors: Li, N. Hiligsmann, M. Boonen, A. et al.

Source: Osteoporosis International. Aug2021, Vol. 32 Issue 8, p1517-1530. 14p. 5 Diagrams, 4 Charts.

Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy.

Authors: Hiligsmann, M. Maggi, S. Veronese, N. et al.

Source: Osteoporosis International. Mar2021, Vol. 32 Issue 3, p595-606. 12p. 5 Charts, 1 Graph.

Burden of disease of type 2 diabetes mellitus: cost of illness and quality of life estimated using the Maastricht Study.

Authors: Janssen, L. M. M. Hiligsmann, M. Elissen, A. M. J. et al.

Source: Diabetic Medicine. Oct2020, Vol. 37 Issue 10, p1759-1765. 7p.

Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF)

Authors: Hiligsmann, M. Cornelissen, D. Vrijens, B. et al.

Source: Osteoporosis International. Nov2019, Vol. 30 Issue 11, p2155-2165. 11p. 1 Chart.

This result is not displayed to guests.
Login for full access.

The economic burden of the postoperative management in surgically treated trauma patients with peri- and/or intra-articular fractures of the lower extremities: A prospective multicenter cohort study.

Authors: Kalmet, PHS Andriessen, MT Maduro, CV et al.

Source: Injury. Feb2022, Vol. 53 Issue 2, p713-718.

Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France.

Authors: Hiligsmann, M. Reginster, J.-Y.

Source: Osteoporosis International. Mar2019, Vol. 30 Issue 3, p649-658. 10p. 4 Charts, 2 Graphs.

Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts' consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation

Authors: Hiligsmann, M. Lewiecki, E.M. Pinto, D. et al.

Source: Osteoporosis International. Jan2019, Vol. 30 Issue 1, p45-57. 13p. 3 Charts.

Burden of disease study of overweight and obesity; the societal impact in terms of cost-of-illness and health-related quality of life.

Authors: Hecker, J. Freijer, K. Hiligsmann, M. et al.

Source: BMC Public Health. 10/24/2022, Vol. 22 Issue 1, p1-13. 13p. 4 Charts, 3 Graphs.

Public health impact and economic evaluation of vitamin D-fortified dairy products for fracture prevention in France.

Authors: Hiligsmann, M. Burlet, N. Fardellone, P. et al.

Source: Osteoporosis International. Mar2017, Vol. 28 Issue 3, p833-840. 8p. 5 Charts, 1 Graph.

Potential cost-effectiveness for using patient decision aids to guide osteoporosis treatment.

Authors: Penton, H. Hiligsmann, M. Harrison, M. et al.

Source: Osteoporosis International. Sep2016, Vol. 27 Issue 9, p2697-2707. 11p. 2 Charts, 3 Graphs.

The development of a personalized patient education tool for decision making for postmenopausal women with osteoporosis.

Authors: Hiligsmann, M. Ronda, G. Weijden, T. et al.

Source: Osteoporosis International. Aug2016, Vol. 27 Issue 8, p2489-2496. 8p. 1 Diagram, 1 Chart.

Cost-effectiveness of personalized supplementation with vitamin D-rich dairy products in the prevention of osteoporotic fractures.

Authors: Ethgen, O. Hiligsmann, M. Burlet, N. et al.

Source: Osteoporosis International. Jan2016, Vol. 27 Issue 1, p301-308. 8p. 1 Diagram, 3 Charts, 1 Graph.

Improving the reporting of economic evaluation in osteoporosis: the value of CHEERS 2022 statement.

Authors: Hiligsmann, M. Li, N. Cooper, C. et al.

Source: Osteoporosis International. Aug2022, Vol. 33 Issue 8, p1641-1642. 2p.

Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group.

Authors: Hiligsmann, M. Salas, M. Hughes, D. A. et al.

Source: Osteoporosis International. Dec2013, Vol. 24 Issue 12, p2907-2918. 12p.

URL: 92554135

Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis.

Authors: Hiligsmann, M. Ben Sedrine, W. Bruyère, O. et al.

Source: Osteoporosis International. Aug2013, Vol. 24 Issue 8, p2291-2300. 10p.

URL: 88936631

Cost-effectiveness of osteoporosis screening followed by treatment: the impact of medication adherence.

Authors: Hiligsmann M Gathon HJ Bruyère O et al.

Source: Value in Health. Jun/Jul2010, Vol. 13 Issue 4, p394-401. 8p.

Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women.

Authors: Hiligsmann, M. Bruyère, O. Reginster, J.-Y.

Source: Osteoporosis International. Jan2010, Vol. 21 Issue 1, p157-165. 9p. 3 Charts, 2 Graphs.

EE137 Comparison of the Cost-Effectiveness of Sequential Treatment with Abaloparatide Followed By Alendronate between US Women and Men at Increased Risk of Fracture.

Authors: Hiligsmann, M. Silverman, S. Singer, A.J. et al.

Source: Value in Health. 2023 Supplement, Vol. 26 Issue 6, pS84-S84. 1p.

PIN125 Country-LED Assessment for Prioritisation on Immunisation - Understanding Country Preferences and the VALUE of Preference Studies for Research and Development of Vaccine Products and Delivery Technologies.

Authors: Caramori, G. Hiligsmann, M. Hutubessy, R. et al.

Source: Value in Health. 2020 Supplement 2, Vol. 23, pS564-S565. 2p.